Analysts Set Liquidia Technologies, Inc. (NASDAQ:LQDA) Target Price at $32.11

Key Points

• Liquidia Technologies, Inc. has received a consensus recommendation of "Buy" from ten research firms, with a twelve-month target price averaging $32.11.
• Insiders have recently sold shares of Liquidia Technologies, with CEO Roger Jeffs selling 20,252 shares at an average price of $14.28, reducing his ownership by 1.91%.
• The company reported a 141.5% increase in revenue compared to the previous year, earning $8.84 million despite posting a loss of ($0.49) per share for the recent quarter.

Shares of Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) have been given an average recommendation of "Buy" by the ten analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $32.1111.

A number of equities analysts recently issued reports on the stock. Wells Fargo & Company increased their target price on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research report on Wednesday, August 13th. Oppenheimer set a $13.00 target price on shares of Liquidia Technologies and gave the company an "underperform" rating in a research report on Monday, May 19th. Wall Street Zen upgraded shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Raymond James Financial increased their target price on shares of Liquidia Technologies from $33.00 to $41.00 and gave the company a "strong-buy" rating in a research report on Wednesday, August 13th. Finally, Needham & Company LLC raised their price objective on shares of Liquidia Technologies from $32.00 to $36.00 and gave the company a "buy" rating in a research report on Tuesday, August 12th.

Insider Activity at Liquidia Technologies

In other news, CFO Michael Kaseta sold 30,000 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $20.00, for a total transaction of $600,000.00. Following the completion of the transaction, the chief financial officer owned 376,412 shares in the company, valued at approximately $7,528,240. This trade represents a 7.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Rajeev Saggar sold 5,327 shares of the firm's stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $14.28, for a total transaction of $76,069.56. Following the transaction, the insider owned 271,413 shares of the company's stock, valued at approximately $3,875,777.64. This trade represents a 1.92% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 90,277 shares of company stock worth $1,469,392. Company insiders own 26.50% of the company's stock.

Hedge Funds Weigh In On Liquidia Technologies

Large investors have recently made changes to their positions in the business. Cetera Investment Advisers boosted its position in shares of Liquidia Technologies by 4.3% during the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock valued at $367,000 after purchasing an additional 1,277 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Liquidia Technologies by 53.4% during the 4th quarter. Deutsche Bank AG now owns 51,075 shares of the company's stock valued at $601,000 after purchasing an additional 17,790 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Liquidia Technologies during the 4th quarter valued at about $218,000. Millennium Management LLC purchased a new stake in Liquidia Technologies during the fourth quarter valued at about $526,000. Finally, GAMMA Investing LLC lifted its stake in Liquidia Technologies by 2,342.7% during the first quarter. GAMMA Investing LLC now owns 43,675 shares of the company's stock valued at $644,000 after buying an additional 41,887 shares in the last quarter. Institutional investors own 64.54% of the company's stock.

Liquidia Technologies Price Performance

LQDA traded up $0.22 on Friday, reaching $27.68. The company had a trading volume of 2,174,424 shares, compared to its average volume of 3,122,468. The company has a fifty day moving average of $18.89 and a 200-day moving average of $16.36. The company has a market capitalization of $2.38 billion, a P/E ratio of -16.28 and a beta of 0.14. The company has a current ratio of 2.49, a quick ratio of 2.41 and a debt-to-equity ratio of 9.84. Liquidia Technologies has a one year low of $8.75 and a one year high of $28.82.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). The company had revenue of $8.84 million during the quarter, compared to the consensus estimate of $3.90 million. Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The company's revenue was up 141.5% on a year-over-year basis. As a group, equities research analysts anticipate that Liquidia Technologies will post -1.51 earnings per share for the current year.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).